Yussuf Poulsen to miss HSV's clash with Augsburg after new injury setback

After an injury-riddled start to his stint at Hamburger SV, Yussuf Poulsen has suffered another setback.The 32-year-old ...

NanoViricides Announces Closing of $6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close

SHELTON, CONNECTICUT / ACCESS Newswire / November 12, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), today ...
OneFootball

"Wait and see": Boldt casts a critical eye over HSV transfers | OneFootball

As sports director, Jonas Boldt guided the fortunes of HSV for five years. However, he expressed reservations regarding the ...

NanoViricides to Present at the Pharma Partnering Summit 2025 in Boston Today, November 14th - NV-387 is Effective Against H3N2

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be ...